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Background: Catheter ablation is a proven therapy of focal atrial tachycardia. However limited information is 
available about the additional value of electroanatomical over conventional mapping methods for this specific 
arrhythmia. Methods: Consecutive catheter ablation procedures of FAT were analyzed in two cardiology centres. 
Only conventional mapping was used in 30 of the 60 procedures whereas additionally CARTO mapping was 
performed in another 30 procedures. Acute, six-month success rate, and procedural data were analyzed. Results: 
Localization of ectopic foci is congruent with previously published data. There was no statistically significant 
difference between procedure time and fluoroscopy time using additionally CARTO mapping, compared to 
conventional mapping only. Acute success rate was higher in procedures guided by CARTO mapping than in 
procedures based on conventional mapping (27/30 vs. 18/30, p = 0.0081). During the 6-month follow-up period 
there was a better outcome (p = 0.045) in case of CARTO guided procedures (success: 11 cases, partial success: 
12 cases, failure: 4 cases) compared to conventional mapping (success: 4 cases, partial success: 18 cases, failure: 
7 cases). Conclusions: Catheter ablation of focal atrial tachycardias using the CARTO electroanatomical mapping 
system seems to provide higher acute and 6-month success rate compared to ablation using conventional mapping 
methods only.
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Symptomatic focal atrial tachycardia (FAT) is relatively rare; it occurs in about 0.46 % of the 
population (19). FAT accounts for 10 to 15% of patients referred for catheter ablation of 
supraventricular tachycardia (SVT) (3, 4, 10, 22, 26), with a higher incidence (10 to 23%) in 
children especially when associated with congenital heart disease (28, 30). The prognosis of 
patients with FAT is usually benign with the exception of incessant forms, which may lead to 
tachycardia-induced cardiomyopathy (5, 28, 30). 
FATs have characteristic anatomical localizations, which has been reported in details 
previously (2, 6, 16, 24, 31). The majority of FATs originate from the right atrium, especially 
from the crista terminalis (13) and coronary sinus (3). Although there are some algorithms to 
predict the site of origin of FAT using the P wave morphology of the surface ECG (11, 20, 
24, 27), the precise localization of the ectopic foci remains often difficult with 12-lead ECG.
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No large studies have been conducted to assess the effect of pharmacologic treatment on 
patients with focal ATs, but both paroxysmal and incessant ATs are reported to be difficult to 
treat medically (23, 24). Interventional therapy is reported as the best and safest therapy for 
patients with drug-refractory AT or incessant AT, especially when tachycardia-induced 
cardiomyopathy has been developed (5, 9, 23, 24, 30). Catheter ablation is now accepted as 
the treatment of choice for this type of tachycardia, the success rate varies between 70 and 
100% (1, 3, 10, 13–16, 18, 21, 23, 25, 29, 30).
Conventional mapping and CARTO electroanatomical mapping are complementary 
during electrophysiological study and catheter ablation. The aim of our study was to evaluate 
the clinical benefit of CARTO electroanatomical mapping system used for ablation of focal 
atrial tachycardias over conventional mapping methods. Acute and six-month success rate of 
FAT ablation as well as procedural data were evaluated in cases performed using conventional 
mapping methods only and in cases with additional mapping using the CARTO system.
To the best of our knowledge there are no comparative data available evaluating the 
additional clinical value of electroanatomical mapping over conventional mapping in a 
consecutive dataset of patients who underwent catheter ablation of focal atrial tachycardia.
Materials and Methods
Patients
Data of consecutive patients underwent catheter ablation of incessant or paroxysmal FAT 
were collected retrospectively in two Hungarian cardiology centres: Cardiology Institute of 
University of Debrecen, Debrecen, Hungary (between 2006 and 2011), and Department of 
Cardiology of Military Hospital, State Health Center, Budapest, Hungary (between 2009 and 
2011).
EP study
The electrophysiology study and catheter ablation procedure was explained to all patients 
and written informed consent was obtained from all of them before the study. Possible 
reversible causes were corrected in all patients. All antiarrhythmic drugs were ceased a 
minimum of five half-lives before the procedure. 
The electrophysiological study was performed using quadripolar electrode catheters 
positioned in the high right atrium, His-bundle region, and right ventricular apex and a 
decapolar electrode catheter positioned in the coronary sinus. A steerable ablation catheter 
was inserted through the right femoral vein for atrial mapping, pacing, and ablation. After the 
atrial tachycardia has been verified using conventional criteria (12) the tachycardia mechanism 
was studied as well, and was considered microreentrant if it could be induced by programmed 
atrial stimulation, and automatic if it was induced by an infusion of isoproterenol and 
triggered activity if it could be induced by burst pacing. The same induction method was used 
after catheter ablation to prove the effect of the lesions.
Mapping of the atrial tachycardia was performed during ongoing atrial tachycardia 
using the already inserted diagnostic and additional deca- or duodecapolar mapping catheters 
according to the operating physician’s preference. Additionally or alternatively to multipolar 
catheter mapping electroanatomical mapping (CARTO) system was selected by the operating 
physician based on individual decision. Aim of the mapping was to localize the earliest 
endocardial potential preceeding the onset of the surface P-wave. 
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System components and technical principles of electroanatomical mapping (CARTO 
XP V9.6 system and Navistar catheter family, Biosense Webster, Inc., Diamond Bar, CA, 
USA) have been previously described in detail (7, 10, 16, 17). Electroanatomical mapping 
was performed during ongoing tachycardia as well, and area of earliest activation with respect 
to the reference electrogram was determined based on three dimensional activation maps 
(Fig. 1).
Fig. 1. Activation map of a right anteroseptal focal atrial tachycardia
Radiofrequency ablation was performed at the site of earliest atrial activation with the 
same catheter used for mapping. Selection of non-irrigated (with 4 mm tip) or irrigated tip 
catheter was based on the operating physician’s preference. RF applications were performed 
during continuous impedance and temperature monitoring. The radiofrequency energy was 
applied in unipolar pulses directed from the catheter tip to an electrode placed in the dorsal 
region. The pre-defined temperature was 60 ºC in cases ablated with non-irrigated catheter 
and 41 °C in cases ablated with irrigated catheter. Radiofrequency energy was started at 20 
W and increased up to 30 W to reach the target temperature and maximum duration was 60 
seconds in all cases.
All the previously mentioned catheters and techniques were available in the two centres 
throughout the investigated time period ensuring the maximal flexibility for choosing the 
mapping strategy. 
Success definition
Acute success was defined as absence and non-inducibility of the FAT by programmed 
extrastimuli, burst atrial pacing and/or isoproterenol administration according to the 
previously clarified mechanism and effective induction methods. The procedure was 
categorized as successful if the tachycardia remained not inducible even at least 30 minutes 
after the last radiofrequency application. Acute failure of the ablation was considered if 
shorter tachycardia episodes remained still inducible, or the duration and/or inducibility of 
FAT episodes decreased, or the applications did not terminate the tachycardia and it remained 
inducible.
At 6 months after discharge, patients were assessed in out-patient consultations, and 
underwent 12-lead ECG and Holter-monitoring. Success was defined as no recurrence of 
FAT episodes without any antiarrhythmic drug therapy during the six-month follow-up. 
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Partial success was defined in case of asymptomatic tachycardia recurrences on 24 h Holter 
monitoring or ECG recordings, or in cases when symptoms regressed on antiarrhythmic drug 
therapy. Failure was defined as the persistence of symptoms either with or without 
antiarrhythmic therapy.
Statistical analysis
Continuous variables are expressed as mean ± standard deviation (SD). Comparisons between 
groups were performed with Chi2 for trend test in case of acute and 6-month success analysis. 
A p value less than 0.05 was considered statistically significant.
Results
Present study comprised 60 procedures (6 repeated ablations) of 54 consecutive patients (39 
females, age 54 ± 17 years). 
Baseline parameters did not differ in the two patient populations (Table I). Fifty patients 
were on antiarrhythmic drugs before the procedure. None of the patients developed 
cardiomyopathy. We noticed hypertension in 21 cases, 5 patients had COPD, 10 patients had 
ischaemic heart disease, 16 of them had other supraventricular arrhythmia as well and 5 of 
them underwent heart surgery earlier. 
Localization of ectopic foci
We found 46 right-sided foci: 14 coronary sinus (CS), 11 crista terminalis (Cr), 7 superior 
vena cava (SVC), 3 parahisian (His), 2 septal, 3 tricuspid annulus, 1 inferior vena cava, 5 
other. There were 16 left-sided foci: 4 distal coronary sinus (CS dist), 3 pulmonary vein (PV), 
3 septal, 3 mitral annulus, 3 other. “Other” category means antero-superior and lateral wall. 
The right- or left-sided origin of one septal focus could not be determined. In 3 procedures 
two distinct foci were found and ablated. There was no significant difference regarding the 
localization of ectopic foci between the two compared groups (Fig. 2). The distribution of the 
localizations is congruent with the previously published data (2, 6, 13, 16, 24, 31).
Ablation procedure
Out of the 60 ablation procedures 30 were mapped with conventional methods only whereas 
in another 30 cases CARTO electroanatomical mapping system was used as well. Additional 
supraventricular tachycardias were found and ablated in 6 cases (Table I). Moreover FAT was 
a secondary finding where atrial flutter was considered as clinical arrhythmia in two cases. 
Most of the focal atrial tachycardias were paroxysmal but 11 incessant cases occurred as well 
(6 of them were ablated with CARTO mapping and 5 cases with conventional mapping 
alone). Acute success rate (Fig. 3) was significantly higher in procedures where CARTO 
mapping was used (27/30, 90%) compared to procedures guided with conventional mapping 
(18/30, 60%, p < 0.01). Similar difference was observed in case of left sided foci: success in 
8/8 (100%) CARTO enhanced procedures compared to 3/6 (50%) in conventionally mapped 
procedures, although this difference was statistically not significant. There was no statistically 
significant difference in the success rate depending on the operating physician or use of 
irrigated and non-irrigated ablation catheters. There was no significant difference between 
procedure time (139 ± 59 vs. 96±44 min, p: ns) and fluoroscopy time (18 ± 12 vs. 11 ± 6 min, 
p: ns) although procedures with CARTO mapping tended to be longer compared to 
conventional mapping. No procedure related complications occurred (Fig. 3).
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Table I. Baseline parameters of the studied population
Conventional mapping CARTO mapping Significance
Number of patients 30 24 ns
     Female 21 18 ns
Age (years, mean ± SD)
(min.–max.)
61 ± 14
(30–83)
48 ± 18
(19–77)
ns
Hypertension 8 13 ns
Diabetes mellitus 4 5 ns
COPD 3 3 ns
Heart surgery 3 2 ns
Ischaemic heart disease 3 7 ns
Valvulopathy 4 3 ns
     MI grade II–III 3 1 ns
     TI grade II–III 1 2 ns
EF (%, mean ± SD)
(min.–max.)
53 ± 12
(25–70)
57 ± 12
(26–76)
ns
Left atrium (mm, mean ± SD)
(min.–max.)
41 ± 7
(27–53)
40 ± 9
(24–59)
ns
Right ventricle systolic pressure > 35 mmHg 4 1 ns
Other arrhythmia beside FAT 2 6 ns
     Atrial flutter 1 3 ns
     AVNRT 1 3 ns
Antiarrhythmic drugs 24 26 ns
     Beta-blockers 15 14 ns
     Amiodarone 1 2 ns
     Propafenone 1 3 ns
     Sotalol 1 0 ns
     Verapamil 2 1 ns
     Combination 4 6 ns
Abbreviations: AVNRT = atrioventricular-nodal reentrant tachycardia, COPD = chronic obstructive pulmonary disease, 
EF = ejection fraction, FAT = focal atrial tachycardia, max. = maximum, min. = minimum, mm = millimeter,  
ns = non-significant, MI = mitral insufficiency, SD = standard deviation, TI = tricuspid insufficiency
Fig. 2. Localization of ectopic foci in the conventional mapping (left side) and CARTO mapping (right side) 
procedures. Absolute numbers of ectopic foci are shown in parenthesis.  
Abbreviations: CS = coronary sinus, Cr = crista terminalis, SVC = superior vena cava, His = parahisian,  
CS dist = distal coronary sinus, PV = pulmonary vein. Other right and other left categories mean septal,  
tricuspid annulus, inferior vena cava, mitral annulus, antero-superior and lateral wall
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Fig. 3. Acute success rate of procedures
Fig. 4. Six-month success rate of procedures
Follow-up
The 6-month follow-up data were available in 56 cases (2 patients were foreign and 2 patients 
died). Patients remained free of FAT (success) in 11 cases after CARTO enhanced procedures 
and in 4 cases after ablation with conventional mapping only. Partial success (12 vs. 18) and 
failure (4 vs. 7) occurred less often in cases with CARTO mapping compared to conventional 
mapping (Fig. 4). Better 6-month outcome was evident in cases where CARTO mapping was 
used compared to procedures by conventional mapping (p = 0.045). Full or partial success was 
found more often in CARTO mapped (85%) than in conventionally mapped (75%) cases. 
Repeated ablation procedure was necessary in 6 cases (after 4 conventionally and 2 CARTO 
mapped procedures), all of them were successfully performed with CARTO mapping.
Discussion
To the best of our knowledge this is the first report directly comparing the additional value of 
CARTO electroanatomical mapping system over conventional mapping methods in the 
treatment of focal atrial tachycardias. In our consecutive patient population better acute 
success rate (90% vs. 60%) and 6-month outcome (85% vs. 75%) was found in CARTO 
enhanced procedures compared to procedures with conventional mapping only (4, 13, 15, 
23, 29).
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The goal of the antiarrhythmic therapy in focal atrial tachycardia is the clinical efficacy, 
to reach a better quality of life when patient’s symptoms decrease or disappear completely. 
Antiarrhythmic treatment of focal atrial tachycardia is usually difficult but catheter ablation 
has been shown to be effective in its treatment, partially in combination with pharmacological 
therapy. Radiofrequency catheter ablation is currently the first-line therapy in all symptomatic 
focal atrial tachycardia cases, especially when cardiac dysfunction develops (4, 23, 24, 30) 
(Table II).
Data of 13 papers reporting results of catheter ablation of focal atrial tachycardias are 
shown in Table II. Direct comparative data of acute and mid-term efficacy of conventional 
mapping and CARTO enhanced catheter ablation had not been reported previously. The 
assessment of procedural data shows that ablation of 67 patients with conventional mapping 
was immediately successful in 91% of cases and the mid- or long-term success rate was 88%. 
On the other hand, 156 ablations guided by CARTO electroanatomical mapping provided 
93% acute and 89% mid- or long-term success rate. A solid meta-analysis of the published 
data is not possible, mostly because of various clinical end-points, different follow-up 
periods, and lack of data. Some authors define mid- or long-term success as the absence of 
arrhythmia without AAD-s confirmed by Holter-monitoring. On the other hand, other 
publications use the criteria of “clinical success”, which means that the patient is free of 
symptoms with or without antiarrhythmic medication. 
Based on data of prior publications, conventional mapping can be still a beneficial 
choice to guide catheter ablation based on the high success rate and lower cost. Moreover, a 
comparison of data does not seem to show any difference between the efficacy of conventional 
mapping and CARTO-enhanced mapping strategies (Table II), although statistical analysis of 
these data was not possible. On the other hand, our data show the superiority of using CARTO 
electroanatomical mapping system in case of ablation of focal atrial tachycardias.
Study limitations
Our retrospective analysis shows that CARTO enhanced procedures are more effective than 
the conventional method alone, however the success rate of conventionally mapped 
procedures is lower than reported previously (13, 15, 29, 30). Moreover, the ablation strategy 
was selected individually by the operating physician, was not randomized, which makes 
the theoretical possibility to quit conventional ablation and plan a second CARTO based 
procedure in difficult cases. However, one has to be aware of the fact that only 2 patients had 
a CARTO based ablation after an acute unsuccessful conventionally mapped procedure, so 
these treatment decisions do not alter our main findings significantly.
Conclusions
CARTO electroanatomical mapping system is a safe and effective method to guide catheter 
ablation of focal atrial tachycardia. Acute and mid-term clinical results seem to be superior in 
case of CARTO electroanatomical mapping compared to conventional mapping in our 
dataset. Therefore CARTO guided ablation seems to be more appropriate as initial ablation 
strategy in case of focal atrial tachycardia.
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